We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
Cap. Flow
-$61.1M
Cap. Flow %
-3.78%
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.14M
2
AVGO icon
Broadcom
AVGO
+$3.01M
3
TSLA icon
Tesla
TSLA
+$2.23M
4
TWST icon
Twist Bioscience
TWST
+$1.76M
5
NVAX icon
Novavax
NVAX
+$1.74M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$26.2M
2
DHR icon
Danaher
DHR
+$17.1M
3
AMGN icon
Amgen
AMGN
+$12.4M
4
GILD icon
Gilead Sciences
GILD
+$9.52M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 33.28%
2 Healthcare 16.86%
3 Consumer Discretionary 11.45%
4 Communication Services 8.63%
5 Energy 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTB icon
551
M&T Bank
MTB
$36B
$427K 0.03%
3,569
+268
+8% +$38.9K
ARGX icon
552
argenx
ARGX
$55.6B
$427K 0.03%
1,145
+88
+8% +$32.6K
AXIA
553
AXIA Energia
AXIA
$22.9B
$426K 0.03%
81,230
-6,069
-7% -$33.9K
CRUS icon
554
Cirrus Logic
CRUS
$6.87B
$425K 0.03%
3,886
+302
+8% +$29.4K
GSK icon
555
GSK
GSK
$104B
$424K 0.03%
11,905
+908
+8% +$31.8K
PCRX icon
556
Pacira BioSciences
PCRX
$1.04B
$423K 0.03%
10,367
+4,363
+73% +$174K
CX icon
557
Cemex
CX
$17.6B
$422K 0.03%
76,334
-3,393
-4% -$17.2K
JBL icon
558
Jabil
JBL
$32.6B
$422K 0.03%
4,787
-792
-14% -$63.8K
MORF
559
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$421K 0.03%
+11,173
New +$412K
ERIC icon
560
Ericsson
ERIC
$31.8B
$419K 0.03%
71,661
+5,466
+8% +$31.2K
MOS icon
561
The Mosaic Company
MOS
$7.1B
$419K 0.03%
9,137
-253
-3% -$12.3K
TSVT
562
DELISTED
2seventy bio
TSVT
$419K 0.03%
+41,071
New +$470K
SWAV
563
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$419K 0.03%
1,932
-469
-20% -$91.4K
RETA
564
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$419K 0.03%
+4,606
New +$270K
CFR icon
565
Cullen/Frost Bankers
CFR
$10.3B
$418K 0.03%
3,971
+990
+33% +$123K
KR icon
566
Kroger
KR
$35.5B
$418K 0.03%
8,468
-1,930
-19% -$88.2K
IRDM icon
567
Iridium Communications
IRDM
$4.87B
$417K 0.03%
6,740
-2,585
-28% -$155K
TDG icon
568
TransDigm Group
TDG
$71.9B
$417K 0.03%
566
+24
+4% +$17.1K
CROX icon
569
Crocs
CROX
$6.69B
$417K 0.03%
3,298
-472
-13% -$57K
EME icon
570
Emcor
EME
$33B
$415K 0.03%
2,552
-334
-12% -$51.4K
VISN
571
Vistance Networks Inc
VISN
$2.67B
$413K 0.03%
64,852
+310
+0.5% +$2.35K
FMC icon
572
FMC
FMC
$1.39B
$413K 0.03%
3,381
-91
-3% -$11.5K
ACM icon
573
Aecom
ACM
$9.12B
$411K 0.03%
4,871
-570
-10% -$49.1K
LHX icon
574
L3Harris
LHX
$56.5B
$409K 0.03%
2,082
+110
+6% +$22.5K
ZBH icon
575
Zimmer Biomet
ZBH
$17.8B
$408K 0.03%
3,157
-455
-13% -$57.1K
21 22
23
24 25

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.

  • Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
  • Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
  • Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
  • Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
  • Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
  • Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.

Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.